Life Science Investing STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
Life Science Investing STAAR Surgical Announces Expiration of "Window Shop" Period; No Competing Acquisition Proposals Received
Life Science Investing Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company's Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
Life Science Investing STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
Life Science Investing STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
SAGA Metals Announces Closing of Fully Subscribed Non-Brokered Private Placement and Provides Corporate Update
